Zark Parking Solutions | Undisclosed Amount | (Jun 13, 2025)
Ryght | $3,000,000 | (Jun 13, 2025)
VectorWave Corporation | $2,500,000 | (Jun 13, 2025)
Certified by Founder
Lodge
Exeliom Biosciences
start up
France
- Dijon, Bourgogne-Franche-Comté
- 21/07/2023
- Series A
- $8,898,320
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
- Industry Pharmaceutical Manufacturing
- Website https://www.exeliombio.com/
- LinkedIn https://www.linkedin.com/company/nextbiotix/
Related People
Benjamin HadidaFounder
France -
Paris, Île-de-France
Biotech company builder and new therapeutic class explorer
OneBalance | $20,000,000 | (Jun 13, 2025)
Tastewise | $50,000,000 | (Jun 13, 2025)
Parallel Bio | $21,000,000 | (Jun 13, 2025)
Piston | $7,500,000 | (Jun 13, 2025)
Iterate.ai | $6,400,000 | (Jun 13, 2025)
Tombot | $6,100,000 | (Jun 13, 2025)
SushiDog | $1,761,410 | (Jun 13, 2025)
Knowunity | $31,134,105 | (Jun 13, 2025)
New Iridium | $2,650,000 | (Jun 12, 2025)